An open label extension study of phase 3 clinical trial of duloxetine in patients with osteoarthritis
Phase 3
- Conditions
- osteoarthritis
- Registration Number
- JPRN-jRCT2080222774
- Lead Sponsor
- Shionogi & Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Consecutive Participants:
Participants who have completed the 15-week treatment in the preceding study (A phase 3 clinical trial of duloxetine in patients with osteoarthritis)
New Participants:
Participants meet the ACR criteria for idiopathic osteoarthritis of the knee.
And et al.
Exclusion Criteria
Participants having a confounding painful condition that may interfere with assessment of the joint.
And et al.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The incidence of both adverse events and adverse drug reactions
- Secondary Outcome Measures
Name Time Method